Syria Pharmaceutical Sales Monitor Audit AMS - Advanced Marketing statistics
Close

Not a member yet? Register now and get started.

lock and key

Sign in to your account.

Account Login

Forgot your password?

Syria Pharmaceutical Sales Monitor Audit

SYRIA PHARMACEUTICAL SALES MONITOR

 

Click here to download sample , ٍSyria Q1 2013[wpdm_file id=22]

INTRODUCTION:

 

THE ( SyPSM ) IS A QUARTERLY PUBLICATION DESIGNED TO ACCURATELY REFLECT THE QUANTITATIVE SALES OF PHARMACEUTICALS IN SYRIA (PRIVATE SECTOR) .

THIS STUDY PROVIDES INFORMATION ON THE ACTIVITY OF PHARMACEUTICAL COMPANIES AND SERVES AS A STATISTICAL TOOL OF ASSESSMENT OF SALES.

OBJECTIVE:

TO PROVIDE THE PHARMACEUTICAL COMPANIES OPERATING IN SYRIA WITH AN ACCURATE TOOL BY WHICH TO MEASURE THEIR SALES AND THE SALES OF THEIR COMPETITORS, ON A REGULAR BASIS.

METHODOLOGY:

1. DATA IS COLLECTED DIRECTLY FROM THE AGENTS, MANUFACTURERS AND DISTRIBUTORS AND INSERTED INTO THE STUDY.

2. A REPRESENTATIVE SAMPLE OF 255 PHARMACIES THROUGHOUT SYRIA ARE VISITED ON A REGULAR BASIS, AND THEIR PURCHASES OF PRODUCTS RECORDED.

THE DATA IS THEN CODED AND PROCESSED BY A COMPUTER PROGRAME. DURING THIS PROCESS STRICT QUALITY CONTROL MEASURES ARE APPLIED. AT THE FINAL STAGE THE DATA IS ANALYSED AND THEN PROJECTED TO THE NATIONAL LEVEL.

SELECTION OF PANEL PHARMACIES:

THE BASIS AND CRITERIA OF SELECTION WERE AS FOLLOWS:

1-      PHARMACIES IN SYRIA WERE CATEGORIZED ACCORDING TO THEIR DAILY TURNOVER

(  A+ ) PHARMACIES                      DAILY TURNOVER ABOVE SL 30000

(  A   ) PHARMACIES                      DAILY TURNOVER ABOVE SL 24000

(  B   ) PHARMACIES                      DAILY TURNOVER ABOVE SL 12000

(  C   ) PHARMACIES                      DAILY TURNOVER BELOW SL 10000

2-      THE WEIGHTED AVERAGE OF EACH GROUP WAS CALCULATED AND FOUR SEPARATE PROJECTION FACTORS DETERMINED.

3-      THE REGIONAL DISTRIBUTION OF PHARMACIES IN SYRIA.

CALCULATION OF VALUES:

THE PHARMACY PRICE IS THE PRICE LEVEL USED TO CALCULATE THE SL VALUE.

THE PHARMACY PURCHASE PRICE IS THE PRINTED UNIT APPEARING NEXT TO EACH PRODUCT.

PHARMACY UNIVERSE VS PANEL 

REGION UNIVERSE SAMPLE
DAMASCUS

1500

45

DAMASCUS REEF

1150

40

HALAB

1500

45

HUMS

900

25

HAMA

700

15

LATHIKIYYA

400

15

TARTOUS

400

15

IDLIB

400

15

DEIR AL ZOUR / RAQA / KAMISHLY

500

15

HASAKEH

250

10

DER’A

400

15

TOTAL

8100

255

PRICE STRUCTURE

 CIF   =     100+13%

Agent Margin   =    113+24.5%

Customs +Insurance& others   =     137.5      (Pharmacies Purchase Price)+17%

Average Pharmacies Margin =   165  (Public Purchase Price)

Public Purchase Price X 0.83  = (Pharmacies Purchase Price)

________________________________________________________________________________________

HOW TO INTERPRET THE LEADING MANUFACTURERS TABLES:

1-      LEADING MANUFACTURERS I (VALUE AND UNITS). THIS TABLE LISTS THE VALUE AND UNIT SALES AND RANKING OF EACH MANUFACTURER INDIVIDUALLY BY NAME.

2-      LEADING MANUFACTURERS II (VALUE AND UNITS). THIS TABLE LISTS THE VALUE AND UNIT SALES AND RANKING OF EACH MANUFACTURER AND IS DESIGNED TO SHOW MULTINATIONAL COMPANIES RANKING AT THE TOTAL LEVEL AND DETAILED BY LOCAL MANUFACTURERS. (A MULTINATIONAL COMPANIES PRODUCTS ARE TYPICALLY PRODUCED IN SYRIA BY ONE OR MORE LOCAL MANUFACTURERS).

3-      LEADING MANUFACTURERS III (VALUE AND UNITS). THIS TABLE LISTS THE VALUE AND UNIT SALES AND RANKING OF ALL MANUFACTURERS AND IS DESIGNED TO SHOW GENERIC AND LICENSED MULTINATIONAL PRODUCT SALES PER LOCAL MANUFACTURER. ADDITIONALY IT SHOWS MULTINATIONAL COMPANIES RANKING FOR IMPORTED PRODUCTS..

[wpdm_file id=4]